Hims & Hers Health
HIMS
113 hedge funds and large institutions have $473M invested in Hims & Hers Health in 2021 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 43 increasing their positions, 12 reducing their positions, and 21 closing their positions.
258% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 12
119% more first-time investments, than exits
New positions opened: 46 | Existing positions closed: 21
37% more call options, than puts
Call options by funds: $14.3M | Put options by funds: $10.4M
28% more funds holding
Funds holding: 88 → 113 (+25)
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
8.62% less ownership
Funds ownership: 40.81% → 32.19% (-8.6%)
42% less capital invested
Capital invested by funds: $815M → $473M (-$342M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$16.3M |
| 2 |
Renaissance Technologies
New York
|
+$13.2M |
| 3 |
Morgan Stanley
New York
|
+$8.23M |
| 4 |
BlackRock
New York
|
+$7.06M |
| 5 |
LCG
Luxor Capital Group
New York
|
+$5.78M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCMNY
Thrive Capital Management (New York)
New York
|
-$102M |
| 2 |
DTA
Disruptive Technology Advisers
Austin,
Texas
|
-$56.3M |
| 3 |
MC
Maverick Capital
Dallas,
Texas
|
-$18.4M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$10.9M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$6.95M |
HIMS Hedge Fund Activity: Q3 2021 in Review
113 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Hims & Hers Health (HIMS) for Q3 2021, worth a combined $473M — down 42% from $815M a quarter earlier.
Buyers outnumbered sellers: 46 funds opened new HIMS positions and 21 closed out — a net gain of 25 holders — while 43 added to existing stakes and 12 trimmed.
The largest buyer was Vanguard Group, adding an estimated $16.3M. The largest seller was Thrive Capital Management (New York), cutting an estimated $102M.
- 113 institutional investors held Hims & Hers Health (HIMS) as of Q3 2021, up from 88 in Q2 2021.
- Funds reported $473M of Hims & Hers Health stock for Q3 2021, down 42% quarter-over-quarter.
- 46 funds opened new Hims & Hers Health positions in Q3 2021 and 21 closed out, a net change of +25 holders.
- The largest Hims & Hers Health buyer in Q3 2021 was Vanguard Group, an estimated $16.3M added.
- The largest Hims & Hers Health seller in Q3 2021 was Thrive Capital Management (New York), an estimated $102M sold.
Based on aggregated 13F filings for Q3 2021.